Clinical Trials · NCT07554417
Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- William Marsh Rice University
- Enrollment
- 20
- Start date
- Apr 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in Skeletal Muscle Mass